Search all trials

Find therapies in clinical trials near you – page 394

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Major depression

Not yet recruiting

Investigational

A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Azetukalner

Contact Research Centre

Breast cancer

Not yet recruiting

Investigational

Study of 6qc-ICG applied to the skin during breast cancer surgery to help surgeons see tumor edges in patients having breast conserving operations

Investigational

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:6QC-ICG

Contact Research Centre

Congenital megacolon

Not yet recruiting

Registered drugNo placebo

Study of sodium butyrate enemas for bowel function recovery after surgery in children and adults with Hirschsprung's disease

Registered drugNo placebo

France

Participants:0–17 years
Substances:Sodium Butyrate

Contact Research Centre

Osteoarthritis

Not yet recruiting

Registered drugNo placebo

Comparing nerve block methods with ropivacaine and epinephrine for pain relief in patients undergoing total knee replacement surgery for knee osteoarthritis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Epinephrine

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Registered drugNo placebo

Testing personalized treatment with acetylsalicylic acid, clopidogrel, and ticlopidine to prevent another stroke in patients with ischemic stroke

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

A study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate